Bladder Disease Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Bladder Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Bladder CancerEndometriosisInterstitial Cystitis+4 more
Centre Hospitalier Universitaire Vaudois232 enrolled4 locationsNCT05726786
Recruiting
Phase 2

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NeoplasmsNeoplasms by SiteUrinary Bladder Neoplasm+8 more
The Netherlands Cancer Institute90 enrolled9 locationsNCT06237920
Recruiting
Not Applicable

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

Bladder CancerNeoplasmsUrinary Bladder Neoplasm+2 more
Cedars-Sinai Medical Center60 enrolled3 locationsNCT04442724
Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting
Not Applicable

Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study

Bladder CancerKidney FailureBladder Disease+1 more
University of California, Los Angeles5 enrolled1 locationNCT06337942
Recruiting

Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation

Bladder CancerInterstitial CystitisRecurrent Cystitis+5 more
Jahn Ferenc South Pest Teaching Hospital300 enrolled2 locationsNCT06719232
Recruiting

Infectious Complications After Cystectomy: A Prospective Observational Study

Bladder CancerInfectionsUrinary Bladder Diseases+5 more
Ludwig-Maximilians - University of Munich200 enrolled1 locationNCT05153694
Recruiting

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

Bladder CancerBladder NeoplasmNon Muscle Invasive Bladder Cancer+8 more
IRCCS San Raffaele20,000 enrolled1 locationNCT06167356